These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38447693)

  • 1. The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D Registry.
    Rammos C; Zeller T; Piorkowski M; Deloose K; Hertting K; Sesselmann V; Tepe G; Gaines P; Lichtenberg M;
    Eur J Vasc Endovasc Surg; 2024 Jun; 67(6):923-932. PubMed ID: 38447693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Multicenter Comparison Between Viabahn Covered Stent-Grafts and Supera Interwoven Nitinol Stents for Endovascular Treatment in Severely Calcified Femoropopliteal Artery Disease: The ARMADILLO Study (Adjusted Retrospective coMparison of scAffolDs In caLcified LesiOns).
    Horie K; Takahara M; Nakama T; Tanaka A; Tobita K; Hayakawa N; Mori S; Iwata Y; Suzuki K
    J Endovasc Ther; 2024 Jun; 31(3):400-409. PubMed ID: 36146948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Case Control Matched Comparison of the Antegrade Versus Retrograde Strategy After Antegrade Recanalisation Failure in Complex de novo Femoropopliteal Occlusive Lesions.
    Trenkler C; Blessing E; Jehn A; Karcher J; Schoefthaler C; Schmidt A; Korosoglou G
    Eur J Vasc Endovasc Surg; 2024 May; 67(5):799-808. PubMed ID: 38182107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helical Centerline Stent Improves Patency: Two-Year Results From the Randomized Mimics Trial.
    Zeller T; Gaines PA; Ansel GM; Caro CG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27208046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vessel Calcification as a Risk Factor for In-Stent Restenosis in Complex Femoropopliteal Lesions After Zilver PTX Paclitaxel-Coated Stent Placement.
    Ichihashi S; Shibata T; Fujimura N; Nagatomi S; Yamamoto H; Kyuragi R; Adachi A; Iwakoshi S; Bolstad F; Saeki K; Obayashi K; Kichikawa K
    J Endovasc Ther; 2019 Oct; 26(5):613-620. PubMed ID: 31257994
    [No Abstract]   [Full Text] [Related]  

  • 6. Post hoc analysis of the SuperB and Zilverpass trials for treatment of long and complex superficial femoral artery lesions.
    van Walraven LA; Kalil VM; van der Veen D; Bosiers MJ; Deloose K; Holewijn S; Zeebregts CJ; Reijnen MMPJ
    J Vasc Surg; 2024 Aug; 80(2):505-514.e2. PubMed ID: 38604319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Femoropopliteal Lesions With the BioMimics 3D Vascular Stent System: Two-Year Results From the MIMICS-2 Trial.
    Sullivan TM; Zeller T; Nakamura M; Gaines PA;
    J Endovasc Ther; 2021 Apr; 28(2):236-245. PubMed ID: 33331207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry.
    Kum S; Ipema J; Chun-Yin DH; Lim DM; Tan YK; Varcoe RL; Hazenberg CEVB; Ünlü Ç
    J Endovasc Ther; 2020 Aug; 27(4):616-622. PubMed ID: 32469296
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative Outcomes of Supera Interwoven Nitinol vs Bare Nitinol Stents for the Treatment of Femoropopliteal Disease: Insights From the XLPAD Registry.
    Armstrong EJ; Jeon-Slaughter H; Kahlon RS; Niazi KA; Shammas NW; Banerjee S
    J Endovasc Ther; 2020 Feb; 27(1):60-65. PubMed ID: 31686573
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary Self-EXPANDing Nitinol Stenting vs Balloon Angioplasty With Optional Bailout Stenting for the Treatment of Infrapopliteal Artery Disease in Patients With Severe Intermittent Claudication or Critical Limb Ischemia (EXPAND Study).
    Schulte KL; Pilger E; Schellong S; Tan KT; Baumann F; Langhoff R; Torsello G; Zeller T; Amendt K; Brodmann M;
    J Endovasc Ther; 2015 Oct; 22(5):690-7. PubMed ID: 26245919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year multicenter experience of standard endovascular treatment of critical limb ischemia in the era of drug-eluting devices.
    Brizzi V; Caradu C; Berard X; Sassoust G; Midy D; Ducasse E
    J Cardiovasc Surg (Torino); 2018 Oct; 59(5):707-715. PubMed ID: 27879958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midterm Outcomes of Common Femoral Endarterectomy Combined with Inflow and Outflow Endovascular Treatment for Chronic Limb Threatening Ischaemia.
    Elbadawy A; Ali H; Saleh M
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):947-955. PubMed ID: 32224037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Calcification on Clinical Outcomes After Endovascular Therapy for Superficial Femoral Artery Disease: Assessment Using the Peripheral Artery Calcification Scoring System.
    Okuno S; Iida O; Shiraki T; Fujita M; Masuda M; Okamoto S; Ishihara T; Nanto K; Kanda T; Takahara M; Uematsu M
    J Endovasc Ther; 2016 Oct; 23(5):731-7. PubMed ID: 27369975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BioMimics 3D vascular stent system for femoropopliteal interventions.
    Lichtenberg M; Zeller T; Gaines P; Piorkowski M;
    Vasa; 2022 Jan; 51(1):5-12. PubMed ID: 34878313
    [No Abstract]   [Full Text] [Related]  

  • 15. PEACE I all-comers registry: patency evaluation after implantation of the 4-French Pulsar-18 self-expanding nitinol stent in femoropopliteal lesions.
    Lichtenberg M; Kolks O; Hailer B; Stahlhoff WF; Tiefenbacher C; Nolte-Ernsting C; Arjumand J; Wittenberg G
    J Endovasc Ther; 2014 Jun; 21(3):373-80. PubMed ID: 24915584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
    Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
    J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity Score Analysis Comparing Clinical Outcomes of Drug-Eluting vs Bare Nitinol Stents in Femoropopliteal Lesions.
    Soga Y; Takahara M; Iida O; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Ando K
    J Endovasc Ther; 2016 Feb; 23(1):33-9. PubMed ID: 26763256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
    Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
    J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.